Medicare Enrolled
Dr. Raul Portillo, MD
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Portillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Portillo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Portillo
Dr. Raul Portillo is a hematology & oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Portillo performed 19,394 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Portillo received a total of $6,020 from 57 pharmaceutical and/or device companies across 251 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Portillo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 33% volume in TX
$6,020 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗19,394
Medicare services
Top 33% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
7,400 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,800 | $0 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,173 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
574 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
428 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
406 | $8 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $61 | $250 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
331 | $10 | $64 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
122 | $21 | $157 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
112 | $59 | $247 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
92 | $97 | $707 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
77 | $6 | $31 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
64 | $11 | $96 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
62 | $13 | $60 |
| Iron level test | 62 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
62 | $8 | $35 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
62 | $272 | $2,762 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
51 | $9 | $56 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
51 | $178 | $700 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 50 | $20 | $128 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $47 | $344 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
49 | $46 | $313 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $41 | $150 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
38 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
38 | $6 | $34 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
36 | $167 | $1,067 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
35 | $44 | $821 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
31 | $1 | $7 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
30 | $35 | $143 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
30 | $21 | $161 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $19 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
19 | $14 | $76 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $90 | $470 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
18 | $14 | $73 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $101 | $565 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
15 | $19 | $99 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
14 | $1,109 | $4,802 |
| New patient office visit, complex (60-74 min) | 14 | $168 | $709 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 14 | $91 | $657 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
12 | $49 | $686 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $89 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.7% high complexity
86.4% medium
11.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,020
Total received (2018-2024)
Avg $860/year across 7 years
Top 40% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
251
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$733
2023
$897
2022
$399
2021
$343
2020
$731
2019
$1,628
2018
$1,289
Payments by company (2024)
GENZYME CORPORATION
$143
Genmab U.S., Inc.
$125
Rigel Pharmaceuticals, Inc.
$112
Novartis Pharmaceuticals Corporation
$108
Takeda Pharmaceuticals U.S.A., Inc.
$100
Merck Sharp & Dohme LLC
$40
Alexion Pharmaceuticals, Inc.
$30
Blueprint Medicines Corporation
$22
ABBVIE INC.
$21
Regeneron Healthcare Solutions, Inc.
$17
Lilly USA, LLC
$16
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$562
Novartis Pharmaceuticals Corporation
$470
Amgen Inc.
$467
Takeda Pharmaceuticals U.S.A., Inc.
$403
Janssen Biotech, Inc.
$362
GENZYME CORPORATION
$339
PFIZER INC.
$273
Gilead Sciences, Inc.
$263
AstraZeneca Pharmaceuticals LP
$232
Rigel Pharmaceuticals, Inc.
$224
Merck Sharp & Dohme LLC
$204
Exelixis Inc.
$177
Genentech USA, Inc.
$141
Merck Sharp & Dohme Corporation
$129
Lilly USA, LLC
$127
Genmab U.S., Inc.
$125
ImmunoGen, Inc.
$125
Stemline Therapeutics Inc.
$110
Incyte Corporation
$109
Verastem, Inc.
$89
Bayer HealthCare Pharmaceuticals Inc.
$76
EMD Serono, Inc.
$66
Astellas Pharma US Inc
$61
Daiichi Sankyo Inc.
$59
Celgene Corporation
$59
Puma Biotechnology, Inc.
$58
Alexion Pharmaceuticals, Inc.
$44
Teva Pharmaceuticals USA, Inc.
$42
EISAI INC.
$42
AbbVie, Inc.
$40
Eisai Inc.
$36
Kite Pharma, Inc.
$29
Seagen Inc.
$29
Pharmacyclics LLC, An AbbVie Company
$29
Clovis Oncology, Inc.
$29
Dendreon Pharmaceuticals LLC
$26
Apellis Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$22
Advanced Accelerator Applications
$21
ABBVIE INC.
$21
Medtronic USA, Inc.
$20
Array BioPharma Inc.
$20
TESARO, Inc.
$19
BeiGene USA, Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
R-Pharm US LLC
$17
MACROGENICS, INC.
$17
Regeneron Healthcare Solutions, Inc.
$17
GlaxoSmithKline, LLC.
$17
Myriad Genetic Laboratories, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
Karyopharm Therapeutics Inc.
$15
APO-PHARMA USA, INC.
$14
Seattle Genetics, Inc.
$13
Kyowa Kirin, Inc.
$13
Dova Pharmaceuticals
$12
Global Blood Therapeutics, Inc.
$12
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · BENDEKA · BLENREP · BRACANALYSIS CDX · BRUKINSA · Bavencio · Braftovi · CABLIVI · CALQUENCE · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DEFERIPRONE · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Epkinly · Erleada · FRUZAQLA · GAZYVA · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · Ixempra · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MARGENZA · MEKINIST · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · OSTEOCOOL RF ABLATION · OXBRYTA · Orserdu · PADCEV · PROMACTA · PROVENGE · Pomalyst · Prolia · RYDAPT · Revlimid · Rezlidhia · Rituxan · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAGRISSO · TASIGNA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · ULTOMIRIS · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xofigo · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
56
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
BAPTIST MEDICAL CENTER
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Portillo is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Portillo experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Portillo performed 7,400 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Portillo receive payments from pharmaceutical companies?
Yes. Dr. Portillo received a total of $6,020 from 57 companies across 251 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Portillo's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Portillo's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Portillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Antonio
Browse hematology & oncology specialists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology